MIRA INFORM REPORT

 

 

Report Date :

15.12.2014

 

IDENTIFICATION DETAILS

 

Name :

MANGALAM DRUGS AND ORGANICS LIMITED

 

 

Registered Office :

3rd Floor, Rupam Building, 239, P D’Mello Road, Mumbai – 400001, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

18.04.1972

 

 

Com. Reg. No.:

11-116413

 

 

Capital Investment / Paid-up Capital :

Rs. 131.782 Millions

 

 

CIN No.:

[Company Identification No.]

L24230MH1972PLC116413

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMM19790B

 

 

PAN No.:

[Permanent Account No.]

AAACM7880P

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer of Bulk Drugs.

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (29)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Maximum Credit Limit :

USD 660000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track.

 

The rating is constrained on account of continuous losses incurred by the company.

 

However, trade relations are reported as fair. Business is active. Payment terms are reported to be slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2014

 

Country Name

Previous Rating

(30.06.2014)

Current Rating

(30.09.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating = B-

Rating Explanation

High risk of default

Date

February 03, 2014

 

 

Rating Agency Name

CRISIL

Rating

Short term rating = A4

Rating Explanation

Minimal degree of safety. it carry very high credit risk.

Date

February 03, 2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DECLINED

 

MANAGEMENT NON CO-OPERATIVE  (CONTACT NO.: 91-22-22616200)

 

 

LOCATIONS

 

Registered/ Corporate Office :

3rd Floor, Rupam Building, 239, P D’Mello Road, Mumbai – 400001, Maharashtra, India

Tel. No.:

91-22 22616200/ 6300/ 8787

Fax No.:

91-22-22619090

E-Mail :

mangalam-drugs@vsnl.com

deshpande@mangalamdrugs.com

contactus@mangalamdrugs.com

Website :

http://www.mangalamdrugs.com

 

 

Factory 1 :

Plot No.187, GIDC Vapi, District – Bulsar – 396195, Gujarat, India

Tel. No.:

91-260-2430598/ 2143

Fax No.:

91-260-2431919

 

 

Factory 2 :

Plot No.1203, GIDC Vapi, District – Bulsar – 396195, Gujarat, India

 

 

DIRECTORS

 

AS ON 31.03.2014

 

Name :

Mr. Goverdhan Dhoot

Designation :

Chairman

Address :

214, Ozeana, 5th Floor, Marine Drive, Mumbai - 400020, Maharashtra, India

Date of Birth/Age :

21.10.1953

Qualification :

Commerce Background

Experience :

He is a Whole-time Director of the Company effective 1st November 2004. He has over three decades of experience in the Chemical Industry, handling marketing in both domestic and export market. He has traveled to many countries and visited important Industrial and Commercial Capitals all over the world.

Date of Appointment :

16.04.1996

DIN No.:

01240086

 

 

Name :

Mr. Subhash C. Khattar

Designation :

Independent Director

Address :

C-7, Swati Apartment, Kalyan Complex, Off Yeri Road, Versova, Andheri, Mumbai - 400061, Maharashtra, India 

Date of Birth/Age :

03.07.1939

Qualification :

Chartered Accountant

Experience :

He is a Chartered Accountant having about 45 years of experience. He specializes in taxation and auditing.

 

He is on the statutory panel of Bank Audits and other public sector under takings (PSUs) and private company.

Date of Appointment :

04.06.2004

DIN No.:

01122941

 

 

Name :

Mr. Rajendraprasad Mimani

Designation :

Independent Director

Address :

35, Jamanlal Bajaj Street, Kolkata - 70007, West Bengal, India

Date of Birth/Age :

02.04.1952

Qualification :

Commerce Background

Experience :

Experience in marketing of various types of products. He has an experience over 36 years.

Date of Appointment :

01.11.2004

DIN No.:

00017399

 

 

KEY EXECUTIVES

 

Name :

Ms. Madhu

Designation :

Admin

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2014

 

Category of Shareholder

Total No. of Shares

Percentage of Holding

(A) Shareholding of Promoter and Promoter Group

 

 

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

3074573

23.33

http://www.bseindia.com/include/images/clear.gifBodies Corporate

2475560

18.79

http://www.bseindia.com/include/images/clear.gifSub Total

5550133

42.12

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

5550133

42.12

(B) Public Shareholding

 

 

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

2954705

22.42

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs. 0.100 Million

3190329

24.21

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs. 0.100 Million

1346101

10.21

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

136980

1.04

http://www.bseindia.com/include/images/clear.gifClearing Members

88540

0.67

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

48440

0.37

http://www.bseindia.com/include/images/clear.gifSub Total

7628115

57.88

Total Public shareholding (B)

7628115

57.88

Total (A)+(B)

13178248

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

 

 

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

Total (A)+(B)+(C)

13178248

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Bulk Drugs.

 

 

Products :

Not Available

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

 

PRODUCTION STATUS (AS ON 31.03.2014)

 

Particulars

Unit

Licensed Capacity

Installed Capacity

Actual Production

 

 

 

 

 

Bulk Drugs and Intermediates

Tons.

N.A.

600

447.31

 

 

 

 

 

 

NOTE:

Installed Capacity varies depends on the product-mix manufactured by the company. From year to year and accordingly figures of Installed Capacity have been regrouped wherever necessary.

 

 

GENERAL INFORMATION

 

Suppliers :

 

Reference :

Not divulged

Name of the Person :

Not divulged

Contact No.:

Not divulged

Since How Long Known :

Not divulged

Experience :

Not divulged

Maximum Limit Dealt :

Not divulged

 

 

Customers :

 

Reference :

Not divulged

Name of the Person :

Not divulged

Contact No.:

Not divulged

Since How Long Known :

Not divulged

Experience :

Not divulged

Maximum Limit Dealt :

Not divulged

 

 

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

v  State Bank of India

v  IDBI Bank Limited

v  Punjab and Maharashtra Co-operative Bank Limited

 

 

Facilities :

 

SECURED LOANS

31.03.2014

(Rs. In Millions)

31.03.2013

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

Term Loans

Rupee Term loans from Banks

244.825

298.298

Motor Car Loan From ICICI Bank Limited

2.252

1.162

SHORT TERM BORROWINGS

 

 

Loans Repayable on demand

311.167

279.127

 

 

 

Total

 

558.244

578.587

 

LONG-TERM BORROWINGS

Term loan from State Bank of India, IDBI Bank, and Punjab and Maharashtra Co-operative Bank Limited are secured by way of;

 

a) First Pari passu charge on entire fixed assets of the company. Both present and future.

b) Second Pari passu charge on entire current assets of the company. Both present and future.

 

 

SHORT TERM BORROWINGS

Working Capital facilities from State Bank of India, IDBI Bank Limited and Punjab and Maharashtra Co-operative Bank Limited is secured by

 

a) First Pari Passu charge on the entire current assets of the company. Both present and future. 

b) Second Pari Passu charge on the entire fixed assets of the company. Both present and future.

 

 

Auditors :

 

Name :

Milwani Associates

Chartered Accountants

Address :

18, Bagaria House, 1st Floor, Kolbhat Lane, Mumbai - 400002, Maharashtra, India

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Associate Companies and others :

v  Raga Organics Private Limited  

v  Mangalam Laboratories Private Limited  

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

20000000

Equity Shares

Rs. 10/- each

Rs. 200.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

13178248

Equity Shares

Rs. 10/- each

Rs. 131.782 Millions

 

 

 

 

 

 

Terms / Right attached to equity shares

 

The Company has one class of issued shares referred to as equity shares having a par value Rs 10/-each holder of equity shares is entitled to one vote per share. The dividend proposed by the board of directors. If any, is subjected to the approval of shareholders in Annual General Meeting. In the event of liquidation of the Company the holder of the equity shares will be entitled to receive remaining assets of the Company after settlement of all preferential amount.

 

The distribution will be in proportion to the number of equity shares held by the equity shareholders.

 

 

Reconciliation of the number of Shares outstanding and the amount of Share Capital as at March 31, 2014

 

Equity Shares (issued Capital)

As at 31-03-2014

 

Numbers

Rs. in Millions

Shares outstanding at the beginning of the year

13,178,248

131.782

Shares issued during the year

--

--

Shares outstanding at the end of the year

13,178,248

131.782

 

 

Shareholders holding more than 5% shares in the Company is set out below:

 

Name of Shareholders

As at 31 March 2014

 

No of Shares held

% of Holding

Shree Kishoriju Trading and Investment Private Limited 

1144522

8.68

Shree Rashbihari Trading and Investment Private Limited 

1139518

8.65

IPCA Laboratories Limited 

1633417

12.39

 

 

LISTING DETAILS:

 

 

Subject Stock Code :

 

BSE : 532637

 

NSE : “MANGALAM”

 

 

Stock Exchange Place :

Not Divulged

 

Listed Date :

Not Divulged

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

131.782

131.782

131.782

(b) Reserves & Surplus

100.447

130.839

248.833

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

232.229

262.621

380.615

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

402.021

439.432

219.564

(b) Deferred tax liabilities (Net)

5.856

14.527

64.525

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

407.877

453.959

284.089

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

313.667

286.627

340.451

(b) Trade payables

208.673

106.976

126.844

(c) Other current liabilities

91.997

37.592

87.454

(d) Short-term provisions

0.000

0.000

0.000

Total Current Liabilities (4)

614.337

431.195

554.749

 

 

 

 

TOTAL

1254.443

1147.775

1219.453

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

533.843

551.337

568.360

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

1.518

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

23.977

22.104

21.079

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

557.820

573.441

590.957

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

1.792

1.844

1.444

(b) Inventories

364.776

310.596

489.846

(c) Trade receivables

296.873

238.706

89.099

(d) Cash and cash equivalents

1.023

0.879

10.268

(e) Short-term loans and advances

32.159

22.309

37.839

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

696.623

574.334

628.496

 

 

 

 

TOTAL

1254.443

1147.775

1219.453

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Revenue from Operations

1223.197

1252.587

1531.819

 

 

Other Income

4.401

15.727

9.540

 

 

TOTAL                                     (A)

1227.598

1268.314

1541.359

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

837.488

810.406

1243.509

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(54.463)

200.528

(157.615)

 

 

Employees benefits expense

102.455

86.719

83.482

 

 

Other expenses

243.655

199.032

221.598

 

 

TOTAL                                     (B)

1129.135

1296.685

1390.974

 

 

 

 

 

Less

PROFIT/ [LOSS] BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

98.463

(28.371)

150.385

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

97.421

100.224

101.643

 

 

 

 

 

 

PROFIT/ [LOSS] BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

1.042

(128.595)

48.742

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

40.105

39.397

37.364

 

 

 

 

 

 

PROFIT/ [LOSS] BEFORE TAX (E-F)                 (G)

(39.063)

(167.992)

11.378

 

 

 

 

 

Less

TAX                                                                  (H)

(8.671)

(49.998)

5.042

 

 

 

 

 

 

PROFIT/ [LOSS] AFTER TAX (G-H)                   (I)

(30.392)

(117.994)

6.336

 

 

 

 

 

 

Earnings/ [Loss] Per Share (Rs.)

(2.31)

(8.95)

0.48

 

 

QUARTERLY RESULTS

 

PARTICULARS

 

 

 

30.06.2014

Type

 

 

1st Quarter

Net Sales

 

 

386.400

Total Expenditure

 

 

350.800

PBIDT (Excl OI)

 

 

35.600

Other Income

 

 

0.200

Operating Profit

 

 

35.800

Interest

 

 

27.100

Exceptional Items

 

 

0.000

PBDT

 

 

8.700

Depreciation

 

 

10.700

Profit Before Tax

 

 

(2.000)

Tax

 

 

0.000

Provisions and contingencies

 

 

0.000

Profit After Tax

 

 

(2.000)

Extraordinary Items

 

 

0.000

Prior Period Expenses

 

 

0.000

Other Adjustments

 

 

0.000

Net Profit

 

 

(2.000)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

PAT / Total Income

(%)

(2.48)

(9.30)

0.41

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

(3.19)

(13.41)

0.74

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(3.11)

(14.64)

0.93

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.17)

(0.64)

0.03

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

3.08

2.76

1.47

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.13

1.33

1.13

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

131.782

131.782

131.782

Reserves & Surplus

248.833

130.839

100.447

Net worth

380.615

262.621

232.229

 

 

 

 

Long-term borrowings

219.564

439.432

402.021

Short term borrowings

340.451

286.627

313.667

Total borrowings

560.015

726.059

715.688

Debt/Equity ratio

1.471

2.765

3.082

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

1531.819

1252.587

1223.197

 

 

(18.229)

(2.346)

 

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

1531.819

1252.587

1223.197

Profit/ (Loss)

6.336

(117.994)

(30.392)

 

0.41%

(9.42%)

(2.48%)

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10488961

16/04/2014

100,000,000.00

PUNJAB & MAHATASHTRA CO-OPERATIVE BANK LIMITED

L.B.S. MARG, BHANDUP (W), MUMBAI, MAHARASHTRA - 400078, INDIA

C03000726

2

10402834

19/01/2013

161,700,000.00

STATE BANK OF INDIA

COMMERCIAL BRANCH, N.G.N. VAIDYA MARG, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

B68021526

3

10364817

16/06/2012

9,000,000.00

PUNJAB AND MAHARASHTRA CO-OPERATIVE BANK LIMITED

CENTRAL OFFICE, 4 & 5, 3RD FLOOR, DREAMS MALL, L.B.S. MARG, BHANDUP (W), MUMBAI, MAHARASHTRA - 400078, INDIA

B43340165

4

10323757

29/12/2011 *

24,000,000.00

PUNJAB & MAHARASHTRA CO-OPERATIVE BANK LIMITED

NO. 4 & 5, 3RD FLOOR, DREAMS MALL, L.B.S. MARG, BHANDUP (W), MUMBAI, MAHARASHTRA - 400078, INDIA

B31051758

5

10298368

26/06/2014 *

135,000,000.00

SBI GLOBAL FACTORS LIMITED

6TH FLOOR, METROPOLITAN BUILDING, BANDRA-KURLA, C 
OMPLEX, BANDRA (EAST), MUMBAI, MAHARASHTRA - 400051, INDIA

C12284584

6

10294777

21/05/2011

40,000,000.00

STATE BANK OF INDIA

N.G.N. VAIDYA MARG, HORNIMAN CIRCLE, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

B16034241

7

10246209

15/10/2010

21,000,000.00

IDBI BANK LIMITED

IDBI TOWERWTC COMPLEX, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

A96695127

8

10195785

31/12/2009

56,000,000.00

STATE BANK OF INDIA

N.G.N VAIDYA MARG, FORT, MUMBAI, MAHARASHTRA - 
400023, INDIA

A76801794

9

10080878

20/12/2007

11,250,000.00

INDUSTRIAL DEVELOPMENT BANK OF INDIA LIMITED

VENKATESH CHAMBERS, GHANSHYAM TALWATKAR MARG, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

A29242880

10

80046564

01/01/2010 *

70,000,000.00

STATE BANK OF INDIA

COMMERCIAL BRANCH, N.G.N VAIDYA MARG,, FORT, MUMBAI, MAHARASHTRA - 400023, INDIA

A77437838

11

80007349

19/01/2013 *

491,000,000.00

STATE BANK OF INDIA

COMMERCIAL BRANCH, N.G.N. VAIDYA MARG, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

B68022078

12

80007360

19/01/2013 *

884,000,000.00

STATE BANK OF INDIA

COMMERCIAL BRANCH, N.G.N. VAIDYA MARG, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

B68021815

 

* Date of charge modification

 

 

UNSECURED LOANS

 

UNSECURED LOANS

31.03.2014

(Rs. In Millions)

31.03.2013

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

From Others

154.944

136.000

Deferred Payment Liabilities

0.000

3.972

SHORT TERM BORROWINGS

 

 

From Others Parties

2.500

7.500

 

 

 

Total

 

157.444

147.472

 

 

REVIEW OF PERFORMANCE:

 

During the year, the Company earned a total income of Rs. 1227.598 Millions as compared to Rs. 1268.314 Millions made in the previous year, a decrease of 3.21% than the previous year. The Company’s losses have considerably reduced to Rs 30.392 Millions as against Rs 117.994 Millions in the previous year basically on account of new and innovative improvements in process development of new dosage forms and drugs delivery system, cost reduction etc. have resulted in improvement in yield which in turn reduced losses considerably.

 

 

FUTURE OUTLOOK:

 

In keeping with the glorious track record of yester years, the company has been successful in augmenting its international market presence in spite of global recessionary pressures. It remains committed to continuously innovate and populate it’s development pipeline with two molecules per quarter. It further remains determined to file and obtain approvals for 5 additional DMFs during next two years. It is the robust regulatory strategy, the prudent partnering and continuous resource restructuring which are going to carve a brighter future for them.

 

 

MANAGEMENT DISCUSSION AND ANALYSIS REPORT

 

INDUSTRIAL STRUCTURE AND DEVELOPMENT:

 

The Indian Pharma Industries today is one of the fastest growing industries in the world. Indian Companies with strict adherence to GMP and those with regulatory approvals are the favoured outsourcing partners for generic companies in regulated market. Domestic Companies see increasing potential in collaborating with foreign companies and seek to capitalize on India’s renowned skills and relatively low cost. In keeping with glorious track record of yester years, the company has been successful in augmenting its international market presence in spite of its global recessionary pressure.

 

 

 

 

 

 

UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH SEPTEMBER 2014

 (Rs. In Millions)

 

SR. NO.

PARTICULARS

QUARTER ENDED 3 MONTHS ENDED

30.09.2014

(UNAUDITED)

30.06.2014

(UNAUDITED)

 

 

 

 

1

Sales/Income from operation(Net of Excise duty)

408.93

385.581

2

Other Operating Income

26.497

0.774

3

Total Net Income from Operation

434.990

386.355

4

Expenditure

 

 

 

(a) Increase / decrease in stock in trade & work in progress

(21.457)

(15.216)

 

(b) Consumption of raw materials

296.408

276.571

 

(c) Employees Cost

27.509

25.318

 

(d) Depreciation

9.363

10.690

 

(e) Other expenditure

74.516

64.106

 

(f) Total

386.339

361.469

5

Profit(+)/Loss(-) from operations before Other income, Finance cost and Exceptional Items(3-4)

48.651

24.886

6

Other income

0.269

0.219

7

Profit (+) / Loss (-) from ordinary activities before

Finance Cost & Exceptional Items(5+6)

48.920

25.105

8

Finance Cost

27.364

27.135

9

Profit(+)/Loss(-) from ordinary activities after Finance cost & Exceptional Items(7-8)

21.556

(2.030)

10

Exceptional Items

0.000

0.000

11

Profit(+)/Loss(-) before Tax (9-10)

21.556

(2.030)

12

Tax Expenses(incl Deferred Tax)

1.500

0.000

13

Net Profit(+)/Loss(-) after Tax (11-12)

20.056

(2.030)

14

Extraordinary Items

0.000

0.000

15

Net Profit(+)/Loss(-) for the period(13-14)

20.056

(2.030)

16

Paid up Equity Share Capital (face value Rs.10/-each)

131.782

131.782

12

Reserves excluding Revaluation Reserves as per balance sheet of previous accounting year.

0.00

0.00

13

Earnings per share (EPS)

 

 

 

(a) Basic and diluted EPS before extraordinary items for the period, for the year to date and for the previous year (not to be annualized)

0.152

(0.15)

 

(b) Basic and diluted EPS after extraordinary items for the period, for the year to date and for the previous year (not to be annualized)

0.152

(0.15)

 

 

 

 

14

Non Promoters Shareholding

 

 

 

- Number of shares

7628115

7628115

 

- Percentage of shareholding

57.88

57.88

15

Promoters and Promoter group Shareholding

 

 

 

a) Pledged/ Encumbered

 

 

 

Number of Shares

5491228

5491228

 

Percentage of Shares (as a % of the total  shareholding of promoter and promoter group

98.84

98.94

 

Percentage of Shares (as a % of the total share capital of the company)

 

 

 

 

41.67

41.67

 

b) Non-encumbered

 

 

 

Number of Shares

58905

58905

 

Percentage of Shares (as a % of the total  shareholding of promoter & promoter group)

1.06

1.06

 

Percentage of Shares (as a % of the total share capital of the company)

0.45

0.45

 

16

Investor Complaints :

3 Months ended 30.09.2014

 

Pending at the Beginning of the quarter

Nil

 

Received during the quarter

Nil

 

Disposed of during the quarter

Nil

 

Remaining unresolved at the end of the quarter

Nil

 

NOTES

 

1)     The above results have been reviewed by the Audit Committee and thereafter, were taken on record by the Board of Directors of the Company at their meeting held on 12th August, 2014.

 

2)     The financial results for the quarter ended 31st March 2014 are balancing figures between audited results for the full financial year and published year to date figure upto the third quarter of the relevant financial year.

 

3)     During the Quarter ended 30th June 2014, 0 Investor complaint were received, all of which have been attended by the company. No complaints were pending at the beginning or at the end of the quarter.

 

4)     As the Company's business activity falls within a single primary business segment viz "Manufacturing of Bulk Drugs "the disclosure requirement of Accounting Standard (AS-17) "Segment Reporting" is not applicable.

 

5)     Previous year figures are regrouped wherever necessary.

 

 

CONTINGENT LIABILITIES:

 

Particulars

31.03.2014

(Rs. In Millions)

31.03.2013

(Rs. In Millions)

A] Performance Guarantees/ Bonds

 

 

(i) Guarantee executed in favor of Assistant Collector of Customs

0.000

1.985

(ii) Guarantee executed in favor of Export Parties.

0.068

0.068

(iii) Guarantee executed in favor of Central Excise

1.487

1.521

 

 

 

B] Others

 

 

(iv) Guarantee given to GSPC Gas Company Limited 

7.513

6.729

(vi) Guarantee given to GPCB

0.700

0.800

 

 

 

Total

 

9.768

11.103


FIXED ASSETS:

 

v  Land

v  Building

v  Plant and Machinery

v  Furniture and Fixtures

v  Motor Care and Vehicles

v  Office and Electrical Equipments

v  Laboratory Equipments

v  Air Conditioner

v  Computer

v  R/D Equipments

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 62.44

UK Pound

1

Rs. 98.15

Euro

1

Rs. 77.38

 

 

INFORMATION DETAILS

 

Information Gathered by :

PRT

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

ART

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

-- PROFITABILITY 

1~10

2

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

29

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.